Vignetti, Marco <br/><br/>
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.  [electronic resource] 

 -  Blood  May 2007 
 - 3676-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-10-052746  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzamides<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--genetics<br/>Humans<br/>Imatinib Mesylate<br/>Male<br/>Middle Aged<br/>Piperazines--administration & dosage<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Pyrimidines--administration & dosage<br/>Remission Induction<br/>Steroids--administration & dosage<br/>Survival Rate